171 related articles for article (PubMed ID: 29356898)
21. Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome.
Neamatallah M; Serria MS; El-Bendary M; El-Gilany AH; Alhawarey A; Abed S; Setate YA; Ammar OA
Br J Biomed Sci; 2022; 79():10237. PubMed ID: 35996514
[No Abstract] [Full Text] [Related]
22. Polymorphisms in
Pineda-Lancheros LE; Gálvez-Navas JM; Rojo-Tolosa S; Membrive-Jiménez C; Valverde-Merino MI; Martínez-Martínez F; Sánchez-Martín A; Ramírez-Tortosa M; Pérez-Ramírez C; Jiménez-Morales A
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986255
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C.
Simili A; Mazzella G; Ravaioli F; Festi D; Bacchi-Reggiani ML; Porro A; Bazzoli F; Azzaroli F
J Gastrointestin Liver Dis; 2019 Dec; 28(4):449-456. PubMed ID: 31826071
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
25. VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.
Cusato J; Allegra S; Boglione L; De Nicolò A; Cariti G; Di Perri G; D'Avolio A
Pharmacogenet Genomics; 2015 Apr; 25(4):164-72. PubMed ID: 25713999
[TBL] [Abstract][Full Text] [Related]
26. Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
Ogawa E; Takayama K; Hiramine S; Hayashi T; Toyoda K
Aliment Pharmacol Ther; 2020 Sep; 52(5):866-876. PubMed ID: 32697871
[TBL] [Abstract][Full Text] [Related]
27. [Vitamin D metabolism and signaling in human hepatocellular carcinoma and surrounding non-tumorous liver].
Horváth E; Balla B; Kósa J; Lakatos PA; Lazáry Á; Németh D; Jozilan H; Somorácz Á; Korompay A; Gyöngyösi B; Borka K; Kiss A; Kupcsulik P; Schaff Z; Szalay F
Orv Hetil; 2016 Nov; 157(48):1910-1918. PubMed ID: 27889974
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus.
Yada M; Miyazaki M; Tanaka K; Masumoto A; Motomura K
World J Gastroenterol; 2018 Apr; 24(13):1478-1485. PubMed ID: 29632428
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.
Dong LM; Ulrich CM; Hsu L; Duggan DJ; Benitez DS; White E; Slattery ML; Farin FM; Makar KW; Carlson CS; Caan BJ; Potter JD; Peters U
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2540-8. PubMed ID: 19706847
[TBL] [Abstract][Full Text] [Related]
31. Human genetics of HCV infection phenotypes in the era of direct-acting antivirals.
Nahon P; Cobat A
Hum Genet; 2020 Jun; 139(6-7):855-863. PubMed ID: 32100095
[TBL] [Abstract][Full Text] [Related]
32. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
Michielsen P; Ho E; Francque S
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival.
Zeljic K; Supic G; Stamenkovic Radak M; Jovic N; Kozomara R; Magic Z
J Oral Pathol Med; 2012 Nov; 41(10):779-87. PubMed ID: 22612324
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection.
Ida H; Hagiwara S; Kono M; Minami T; Chishina H; Arizumi T; Takita M; Yada N; Minami Y; Ueshima K; Nishida N; Kudo M
Dig Dis; 2017; 35(6):565-573. PubMed ID: 29040989
[TBL] [Abstract][Full Text] [Related]
35. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
36. Association of SNPs in interferon receptor genes in chronic hepatitis C with response to combined therapy of interferon and ribavirin.
Heidari Z; Shahzamani K; Ghanbari R; Tahamsebifar A
Acta Med Iran; 2014; 52(10):740-7. PubMed ID: 25369007
[TBL] [Abstract][Full Text] [Related]
37. Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease.
Ogata F; Kobayashi M; Akuta N; Osawa M; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
Oncology; 2017; 93(2):92-98. PubMed ID: 28448999
[TBL] [Abstract][Full Text] [Related]
38. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
39. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
40. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
Calvaruso V; Cabibbo G; Cacciola I; Petta S; Madonia S; Bellia A; Tinè F; Distefano M; Licata A; Giannitrapani L; Prestileo T; Mazzola G; Di Rosolini MA; Larocca L; Bertino G; Digiacomo A; Benanti F; Guarneri L; Averna A; Iacobello C; Magro A; Scalisi I; Cartabellotta F; Savalli F; Barbara M; Davì A; Russello M; Scifo G; Squadrito G; Cammà C; Raimondo G; Craxì A; Di Marco V;
Gastroenterology; 2018 Aug; 155(2):411-421.e4. PubMed ID: 29655836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
